PLA2G4A Antikörper (pSer505)
Kurzübersicht für PLA2G4A Antikörper (pSer505) (ABIN1387828)
Target
Alle PLA2G4A Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- pSer505
-
Kreuzreaktivität
- Maus
-
Homologie
- Human,Rat,Horse,Rabbit
-
Aufreinigung
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic phosphopeptide derived from human CPLA2 around the phosphorylation site of Ser505 [PL(p-S)PL]
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
WB 1:300-5000
ELISA 1:500-1000
IHC-P 1:200-400
IHC-F 1:100-500
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200
ICC 1:100-500 -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 μg/μL
-
Buffer
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
-
Haltbarkeit
- 12 months
-
-
- PLA2G4A (Phospholipase A2, Group IVA (Cytosolic, Calcium-Dependent) (PLA2G4A))
-
Andere Bezeichnung
- CPLA2
-
Hintergrund
-
Synonyms: Cytosolic phospholipase A2, cPLA2, Phospholipase A2 group IVA, PLA2G4A, CPLA2, PLA2G4, PA24A_HUMAN.
Background: Selectively hydrolyzes arachidonyl phospholipids in the sn-2 position releasing arachidonic acid. Together with its lysophospholipid activity, it is implicated in the initiation of the inflammatory response.
-
Gen-ID
- 5321
-
UniProt
- P47712
-
Pathways
- Inositol Metabolic Process, G-protein mediated Events, VEGF Signaling
Target
-